🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A prospective, Phase 3, multi center, single-arm, imaging study investigati...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-05-04
Trial ID
NCT04186845
Treatments Being Tested
This phase II trial evaluates an imaging technique called 18F-rhPSMA-7.3 po...
Status
Recruiting
Location
Emory University Hospital
Start Date
2025-04-18
Trial ID
NCT06865768
This is a randomized, open-label, pilot study assessing the impact of a sho...
Status
Not Yet Recruiting
Location
Washington University School of Medicine
Start Date
2026-07-31
Trial ID
NCT07593079
This phase I trial tests the safety, side effects and best dose of radiolig...
Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2023-11-29
Trial ID
NCT06105918
The goal of this clinical trial is to learn if serial PSMA-PET/CT scans can...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2024-06-30
Trial ID
NCT06479187
Treatments Being Tested
To evaluate the effectiveness of a PSMA-PET scan in identifying recurrent p...
Status
Recruiting
Location
John Theurer Cancer Center at Hackensack University Medical Center
Start Date
2025-10-01
Trial ID
NCT07011342
Treatments Being Tested
This clinical trial evaluates the use of an imaging scan (18F-rhPSMA-7.3 po...
Status
Recruiting
Location
Mayo Clinic in Florida
Start Date
2024-06-11
Trial ID
NCT06389786
This early phase I trial evaluates whether a new imaging technique using fl...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2025-11-14
Trial ID
NCT07164027
The purpose of this study is to investigate the usefulness of PET/MRI with ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-30
Trial ID
NCT05707182
Treatments Being Tested